immunotherapy
209 projects
H2020Doctoral network2021–2025Netherlands
CONSENSE · A game change in continuous biosensing: Molecularly engineered affinity-based nanoswitches for personal monitoring
11 partners · 6 countries
H2020Individual fellowship2021–2023Spain
P70-IMMUNEBREAST · Tumor compartment-specific effects of P70S6K in early triple negative breast cancer: regulation of antitumor immune response and therapeutic implications
H2020Individual fellowship2021–2023United Kingdom
Glycan-PMN · Probing DC-SIGN-glycan multivalent interaction and dendritic cell immune regulation using polyvalent multifunctional glycan-gold nanoparticles
H2020Individual fellowship2021–2024Germany
Tumour T cells · The fate and therapeutic potential of human neoantigen-specific T cells
H2020Individual fellowship2021–2023France
CHECKMATE · deCiphering tHE chemo-mechanical CrosstalK between Macrophages And Tumor cElls
H2020Individual fellowship2021–2023Switzerland
GlioTarget · Inflaming the microenvironment of glioblastoma tumors by ADAR1 inhibition: a two-hit approach for the treatment of brain cancer.
H2020Doctoral network2020–2024Italy
DIRNANO · Directing the immune response through designed nanomaterials
12 partners · 8 countries
H2020Individual fellowship2020–2022Netherlands
SMPSBN · Single molecule protein sequencing using biological nanopores
H2020Individual fellowship2020–2022Belgium
cellsIMPACT · Understanding resistance to immune checkpoint inhibitors by mapping the tumor-host ecosystem at single-cell resolution
H2020Individual fellowship2020–2022United Kingdom
PAC Synthesis · Synthesis of PROTAC-Antibody Conjugate for Application in Acute Myeloid Leukemia Therapy
H2020Individual fellowship2020–2022Spain
PRECISMEDLYM · Aggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine.
H2020Individual fellowship2020–2023United Kingdom
TGF-BTB · Transforming Growth Factor – Bench To Bedside. Towards a better understanding of TGF-β isoform specific signalling in health and disease
2 partners · 2 countries
H2020Individual fellowship2020–2022Sweden
MITafterVIT · Unravelling maintenance mechanisms of immune tolerance after termination of venom immunotherapy by means of clonal mast cell diseases
H2020Individual fellowship2020–2022Belgium
BraINstorm · Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment
H2020Individual fellowship2020–2022Belgium
TESTIMONY · Tumor Endothelial Cells: Gatekeepers Of Anti-Tumor Immunity
H2020Individual fellowship2020–2022Israel
MelImmuneOrg · Deciphering the tumor-immune-microenvironment profile and organization within the tumors of melanoma patients undergoing immunotherapy
H2020Doctoral network2020–2024Ireland
NATURE-ETN · Nucleic Acids for Future Gene Editing, Immunotherapy and Epigenetic Sequence Modification
10 partners · 6 countries
H2020Individual fellowship2020–2022France
MIMIC · Deciphering how microbiota modulate anti-tumor immune responses in checkpoint therapy
H2020Individual fellowship2020–2022Sweden
SYNKIT · Synthetic Natural Killer Cells for Immunotherapy
H2020Doctoral network2019–2024Germany
Magicbullet Reloaded · Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy
15 partners · 6 countries
H2020Doctoral network2019–2024Germany
PAVE · A nanovaccine Approach for the treatment of Pancreatic Cancer
15 partners · 7 countries
H2020Individual fellowship2019–2021Spain
SPLITVAC · Harnessing the innate and adaptive immune system with targeted neoantigen based cancer vaccines
H2020Individual fellowship2019–2021Denmark
ARGONAUT · from the synthesis of gAnglioside tumouR antiGens to a platfOrm for caNcer Active immUnoTherapy
H2020Individual fellowship2019–2021Spain